Review expert faculty discussion of BTK inhibitor resistance in CLL including optimal testing and treatment sequencing to overcome resistance to prior therapy
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/hematology/btki-resistance-in-cll-3/28307-53802
- Start Date: 2024-10-01 05:00:00
- End Date: 2024-10-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 150000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest